Results 141 to 150 of about 25,222 (249)

Syndemic Classes of Unhealthy Alcohol Use Reveal Inequities in Alcohol‐Related Consequences and HIV Care Outcomes

Alcohol, Clinical and Experimental Research, Volume 50, Issue 9, September 2026.
Among 4574 adults with HIV in Kaiser Permanente Northern California, latent class analysis identified four syndemic classes combining alcohol use with co‐occurring conditions: Heavy Use/Complex Behavioral Multimorbidity, Moderate Use/High Cardiometabolic Burden, Low Use/High Medical Morbidity, and Moderate Use/Low Morbidity.
Natalia Van Doren, Michael J. Silverberg, Varada Sarovar, Tory Levine, Alexandra Lea, Stacy A. Sterling, Vanessa A. Palzes, Felicia W. Chi, Andrea H. Kline‐Simon, Maha N. Mian, Elena Cyrus, Lunthita M. Duthely, Typhanye Dyer, Angela M. Heads, Michael Horberg, Janice Y. Tsoh, Derek D. Satre   +16 more
wiley   +1 more source

Serum naltrexone and 6-beta naltrexol concentrations in detoxified addicts during long term naltrexone treatment

, 1992
The pourpose of the present study was to evaluate naltrexone and 6-b-naltrexol plasma time course during long term treatment in the usual clinical setting, in drug addicts.
Dell'Utri A, Avico U, Ferretti C, FERRARI, Anna, Trenti T, Sternieri E, Macchia T, BERTOLOTTI, Marco   +7 more
core  

A Role for Glycine Transporter‐2 Inhibitors in Regulating Accumbal Dopamine Levels and Voluntary Alcohol Intake in Rats

Alcohol, Clinical and Experimental Research, Volume 50, Issue 9, September 2026.
Partial inhibition of glycine transporter‐2 (GlyT2) elevates basal dopamine levels in the nucleus accumbens and abolishes the alcohol deprivation effect in rats. The findings reveal a role for GlyT2‐expressing glycinergic neurons in regulating mesolimbic dopamine signaling and relapse‐like alcohol drinking, highlighting GlyT2 as a potential target for ...
Yasmin Olsson, Klara Danielsson, Ana Domi, Helga Lidö, Linda Engström Ruud, Mia Ericson, Bo Söderpalm   +6 more
wiley   +1 more source

Plasma time-course of naltrexone and 6beta-naltrexol after oral naltrexone administration in patients with liver cirrhosis

, 1993
BACKGROUND/AIMS: Naltrexone has been proposed as a possible treatment of pruritus in cholestasis.These studies were undertaken to evaluate the effect of liver cirrhosis on the plasma time-course of naltrexone.
FERRARI, Anna, Trenti T, Sternieri E., Carulli N, VITALE, Giovanni, BERTOLOTTI, Marco   +5 more
core  

Predictive validity of Alcohol Use Disorder Identification Test – Consumption (AUDIT‐C) for register‐based alcohol‐attributable events among general‐population men and women of different ages

Addiction, Volume 121, Issue 9, Page 2330-2340, September 2026.
Abstract Background and aims Originally developed for clinical screening for hazardous alcohol use, the Alcohol Use Disorder Identification Test – Consumption (AUDIT‐C) is also widely used in epidemiological research and monitoring. However, its cutoff values may not suit all purposes, and evidence on its predictive validity is limited. We examined how
Pia Mäkelä, Jaakko Reinikainen, Sarah Callinan, Marke Jääskeläinen, Kaisa Kuurne, Tomi Lintonen, Solja Niemelä, Jonna Levola   +7 more
wiley   +1 more source

The association between naloxone distribution, buprenorphine treatment and retention and incident high‐risk opioid prescribing with opioid overdose death in Kentucky, Massachusetts, New York and Ohio, United States: An exploratory community‐level cohort study of data from the HEALing Communities Study

Addiction, Volume 121, Issue 9, Page 2482-2493, September 2026.
Abstract Aim We evaluated whether community‐level naloxone distribution, medication for opioid use disorder treatment and retention and incident high‐risk opioid prescribing rates were associated with opioid overdose death rates. Design Observational cohort conducted using 2019 to 2023 community‐level data as an exploratory analysis of the HEALing ...
Alexander Y. Walley, Debbie M. Cheng, Nathan Vandergrift, Marc Larochelle, JaNae Holloway, Jennifer L. Brown, Redonna Chandler, Laura C. Fanucchi, Daniel J. Feaster, Patricia R. Freeman, Timothy Hunt, Michelle R. Lofwall, Hannah K. Knudsen, Edward V. Nunes, Emmanuel Oga, Douglas R. Oyler, Jeffrey H. Samet, Jennifer Villani, Sharon L. Walsh, T. John Winhusen   +19 more
wiley   +1 more source

Naltrexone for the management of opioid dependence.

, 2007
Naltrexone is recommended as a treatment option for people who have been opioid dependent but who have stopped using opioids, and who are highly motivated to stay free from the drugs in an abstinence programme.

core  

Factors associated with readmission to residential treatment among clients transitioned from detoxification services in Alberta, Canada

The American Journal on Addictions, Volume 35, Issue 5, Page 615-621, September 2026.
Abstract Background and Objectives Readmission to residential treatment increases healthcare costs, strains publicly funded systems, and may not adequately meet clients' needs. This study examined rates and predictors of readmission to residential treatment among clients transitioned from detoxification services.
Abreham Mekonnen
wiley   +1 more source

Early cardiovascular and respiratory changes after etorphine immobilization and naltrexone reversal in sheep. [PDF]

Front Vet Sci
Binetti A, Rattanathanya H, Pohlin F, Auer U, Schramel JP, Dolezal M, Kalogeropoulu S, Gösele CL, Stahl L, Ebenhofer LJ, Braun C, Stalder G, Mosing M.   +12 more
europepmc   +1 more source

Evaluation of Naltrexone as a treatment for amphetamine dependence

, 2007
Amphetamine addiction is a disease that affects millions of people worldwide and lacks effective treatment. An estimated 35 million persons are reported to abuse amphetamines, which is more than the total number of cocaine and heroin abusers combined.
Nitya Jayaram-Lindström (317917)
core